Lightbridge Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Stock-Based Compensation (Tables)

Stockholders' Equity and Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Stockholders Equity And Stock-based Compensation

	March 31,		December 31,
*Outstanding Warrants*	2019		2018
Issued to Investors on October 25, 2013, entitling the holders to purchase 250,000 common shares in the Company at an exercise price of $11.50 per common share up to and including April 24, 2021. In 2016, 59,450 of these warrants were exchanged for common stock, and all remaining warrant holders agreed to new warrant terms, which excluded any potential net cash settlement provisions in exchange for a reduced exercise price of $6.25 per share.		163,986		163,986

Issued to Investors on November 17, 2014, entitling the holders to purchase 546,919 common shares in the Company at an exercise price of $11.55 per common share up to and including May 16, 2022. On June 30, 2016, the warrant holders agreed to new warrant terms, which excluded any potential net cash settlement provisions in order to classify them as equity in exchange for a reduced exercise price of $6.25 per share.		546,919		546,919

Issued to an investment bank and subsequently transferred to a principal of the investment bank regarding the Series B Preferred Stock investment on January 30, 2018, entitling the holder to purchase 133,432 common shares in the Company at an exercise price of $1.50 per share, up to and including January 30, 2021.		133,432		133,432

Total		844,337		844,337

Schedule of Share-based Compensation, Stock Options, Activity

	Three Months ended March 31,
	2019		2018

Research and development expenses	$	170,134	$	503,217
General and administrative expenses		164,879		769,818
Total stock-based compensation expense	$	335,013	$	1,273,035

Schedule of weighted average years remaining of expected life activity

Expected volatility		90	%
Risk free interest rate		2.84	%
Dividend yield rate		0	%
Weighted average years		9.8 months
Closing price per share – common stock	$	0.88

Schedule of Stock option transactions of the employees

Stock option transactions to the employees, directors and consultants are summarized as follows for the three months ended March 31, 2019:

	Options Outstanding			Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
Beginning of the period		5,604,154		$	2.72	$	1.96
Granted		-			-		-
Exercised		-			-		-
Forfeited		(215,598	)		2.44		1.75
Expired		(46,364	)		19.10		18.47
End of the period		5,342,192		$	2.59	$	1.82

Options exercisable		3,673,176		$	3.36	$	2.34

Stock option transactions of the employees, directors, and consultants are summarized as follows for the year ended December 31, 2018:

	Options Outstanding			Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
Beginning of the year		3,976,884		$	3.58	$	2.49
Granted		1,784,455			0.90		0.70
Exercised		-			-		-
Forfeited		(143,980	)		1.10		0.83
Expired		(13,205	)		30.60		21.13
End of the year		5,604,154		$	2.72	$	1.96

Options exercisable		3,935,138		$	3.50	$	2.49

Schedule of Non-Vested Options, Activity

	Shares			Weighted- Average Fair Value Grant Date		Weighted Average Exercise Price

Non-vested – December 31, 2017		1,542,736		$	1.10	$	1.58
Granted		1,784,455			0.70		0.90
Vested		(1,514,195	)		1.27		1.58
Forfeited		(143,980	)		0.83		1.10
Non-vested – December 31, 2018		1,669,016		$	0.54	$	0.91

Granted		-			-		-
Vested		-			-		-
Forfeited		-			-		-
Non-vested – March 31, 2019		1,669,016		$	0.54	$	0.91

Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The following table provides certain information with respect to the above-referenced stock options that were outstanding and exercisable at March 31, 2019:

	Stock Options Outstanding						Stock Options Vested
	Weighted						Weighted
	Average						Average
	Remaining				Weighted		Remaining				Weighted
	Contractual		Number		Average		Contractual		Number		Average
	Life		of		Exercise		Life		of		Exercise
Exercise Prices		-Years	Awards		Price			-Years	Awards		Price

$0.90-$1.04		9.35		1,616,402	$	0.90		-		-	$	-
$1.05-$2.00		8.32		2,397,193	$	1.18		8.31		2,344,579	$	1.19
$2.01-$6.00		6.61		787,760	$	4.59		6.61		787,760	$	4.59
$6.01-$20.00		3.95		465,850	$	7.49		3.95		465,850	$	7.49
$20.01-$43.25		0.79		74,987	$	32.87		0.79		74,987	$	32.87
Total		7.89		5,342,192	$	2.59		7.24		3,673,176	$	3.36

The following table provides certain information with respect to the above-referenced stock options that were outstanding and exercisable at December 31, 2018:

	Stock Options Outstanding						Stock Options Vested
	Weighted						Weighted
	Average						Average
	Remaining				Weighted		Remaining				Weighted
	Contractual		Number		Average		Contractual		Number		Average
	Life		of		Exercise		Life		of		Exercise
Exercise Prices		-Years	Awards		Price			-Years	Awards		Price

$0.90-$1.04		9.60		1,616,402	$	0.90		—		-	$	—
$1.05-$2.00		8.57		2,560,330	$	1.18		8.56		2,507,716	$	1.18
$2.01-$6.00		6.86		813,583	$	4.59		6.86		813,583	$	4.59
$6.01-$20.00		4.16		501,334	$	7.48		4.16		501,334	$	7.48
$20.01-$43.25		0.72		112,505	$	29.46		0.72		112,505	$	29.46
Total		8.07		5,604,154	$	2.72		7.42		3,935,138	$	3.50

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details